New ALS drug tested for safety in small trial
NCT ID NCT04632225
First seen Nov 01, 2025 · Last updated May 19, 2026 · Updated 26 times
Summary
This study tested the safety of an experimental drug called engensis in 18 people with amyotrophic lateral sclerosis (ALS), a disease that weakens muscles over time. Participants received either engensis or a placebo injection into their muscles. The main goal was to check for side effects, while also exploring whether the drug might help with muscle strength, daily function, and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Austin Neuromuscular Center
Austin, Texas, 78759, United States
-
Hanyang University Medical Center
Seoul, 04763, South Korea
-
Johns Hopkins University Department of Neurology
Baltimore, Maryland, 21205, United States
-
Northwestern University
Chicago, Illinois, 60611, United States
-
St. Joseph's Hospital and Medical Center, Barrows Neurological Institute
Phoenix, Arizona, 85013, United States
Conditions
Explore the condition pages connected to this study.